Obesity in the Elderly Diabetic Patient
暂无分享,去创建一个
[1] Jaakko Tuomilehto,et al. Determinants for the Effectiveness of Lifestyle Intervention in the Finnish Diabetes Prevention Study , 2008, Diabetes Care.
[2] M. Schulze. Determinants for the Effectiveness of Lifestyle Intervention in the Finnish Diabetes Prevention Study , 2008, Diabetes Care.
[3] R. R. Wolfe,et al. The danger of weight loss in the elderly , 2008, The journal of nutrition, health & aging.
[4] A. Scheen,et al. CB1 Receptor Blockade and its Impact on Cardiometabolic Risk Factors: Overview of the RIO Programme with Rimonabant , 2008, Journal of neuroendocrinology.
[5] Nick Finer,et al. Management of Obesity in Adults: European Clinical Practice Guidelines , 2008, Obesity Facts.
[6] C. Apovian,et al. Obesity surgery: evidence for diabetes prevention/management. , 2008, Journal of the American Dietetic Association.
[7] W. James. The epidemiology of obesity: the size of the problem , 2008, Journal of internal medicine.
[8] N. Basso,et al. Safety and Efficacy of Laparoscopic Adjustable Gastric Banding in the Elderly , 2008, Obesity.
[9] A. Levy. Stem Cells, Hormones and Pituitary Adenomas , 2007, Journal of neuroendocrinology.
[10] Long term pharmacotherapy for obesity and overweight: updated meta-analysis , 2007, BMJ : British Medical Journal.
[11] D. Lau,et al. overweight: updated meta-analysis Long term pharmacotherapy for obesity and , 2007 .
[12] J. Després,et al. International Day for the Evaluation of Abdominal Obesity (IDEA): A Study of Waist Circumference, Cardiovascular Disease, and Diabetes Mellitus in 168 000 Primary Care Patients in 63 Countries , 2007, Circulation.
[13] J. Lau,et al. Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. , 2007, JAMA.
[14] G. Wittert,et al. Management of obesity in patients with type 2 diabetes mellitus. , 2007, Current diabetes reviews.
[15] H Buchwald,et al. Inter-disciplinary European guidelines on surgery of severe obesity , 2007, International Journal of Obesity.
[16] M. Jensen,et al. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study , 2006, The Lancet.
[17] Simon Smyth,et al. Diabetes and obesity: the twin epidemics , 2006, Nature Medicine.
[18] L. Gaal,et al. What is the relationship between risk factor reduction and degree of weight loss , 2005 .
[19] J. Miles,et al. The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes , 2005, Expert opinion on pharmacotherapy.
[20] S. Kritchevsky,et al. Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. , 2005, The American journal of clinical nutrition.
[21] Paul Zimmet,et al. The metabolic syndrome—a new worldwide definition , 2005, The Lancet.
[22] T. Harris,et al. Health consequences of obesity in the elderly: a review of four unresolved questions , 2005, International Journal of Obesity.
[23] R. Vettor,et al. Effect of sibutramine on weight management and metabolic control in type 2 diabetes: a meta-analysis of clinical studies. , 2005, Diabetes care.
[24] S. Wannamethee,et al. Overweight and obesity and weight change in middle aged men: impact on cardiovascular disease and diabetes , 2005, Journal of Epidemiology and Community Health.
[25] Claude Bouchard,et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. , 2004, The New England journal of medicine.
[26] D. Arterburn,et al. The Coming Epidemic of Obesity in Elderly Americans , 2004, Journal of the American Geriatrics Society.
[27] L. Sjöström,et al. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. , 2004, Diabetes care.
[28] Karen C Johnson,et al. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. , 2003, Controlled clinical trials.
[29] From the Centers for Disease Control and Prevention. Public health and aging: trends in aging--United States and worldwide. , 2003, JAMA.
[30] A. Scheen,et al. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat. , 2002, Diabetes & metabolism.
[31] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[32] C. Ritchie,et al. Sarcopenia, weight loss, and nutritional frailty in the elderly. , 2002, Annual review of nutrition.
[33] L. Gaal,et al. The importance of obesity in diabetes and its treatment with sibutramine , 2001, International Journal of Obesity.
[34] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[35] S. Vale,et al. Psychoneuroendocrine characteristics of common obesity clinical subtypes , 2001, International Journal of Obesity.
[36] A. Hofman,et al. A comparison of body mass index, waist–hip ratio and waist circumference as predictors of all-cause mortality among the elderly: the Rotterdam study , 2001, International Journal of Obesity.
[37] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[38] F. Pi‐Sunyer. Weight loss and mortality in type 2 diabetes. , 2000, Diabetes care.
[39] M. Thun,et al. Intentional Weight Loss and Mortality among Overweight Individuals with Diabetes O R I G I N a L a R T I C L E , 2022 .
[40] J. Halter,et al. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults , 2000, Journal of epidemiology and community health.
[41] J. Seidell,et al. Body weight and weight change and their health implications for the elderly , 2000, European journal of clinical nutrition.
[42] S. Wannamethee,et al. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. , 1999, Diabetes care.
[43] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[44] Uk-Prospective-Diabetes-Study-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.
[45] R. Micciolo,et al. Effects of age on body fat distribution and cardiovascular risk factors in women. , 1997, The American journal of clinical nutrition.
[46] R N Pierson,et al. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? , 1996, American journal of epidemiology.
[47] P J Garry,et al. Cross-sectional age differences in body composition in persons 60+ years of age. , 1995, The journals of gerontology. Series A, Biological sciences and medical sciences.
[48] H. Nakano,et al. [Obesity in the elderly]. , 1995, Nihon rinsho. Japanese journal of clinical medicine.
[49] 小谷 一晃. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese , 1994 .
[50] Y. Matsuzawa,et al. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. , 1994, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.
[51] P. Garthwaite,et al. Obesity, Weight Loss and Prognosis in Type 2 Diabetes , 1990, Diabetic medicine : a journal of the British Diabetic Association.
[52] J. Tobin,et al. Studies in the distribution of body fat. II. Longitudinal effects of change in weight. , 1989, International journal of obesity.